RA Capital Healthcare Fund LP's Form 4 filing
Mineralys Therapeutics, Inc. (MLYS) · filed Sep 8, 2025
- Accession no.
- 0001415889-25-023893
- Filed
- Sep 8, 2025, 5:59 PM ET
- Trade date
- Sep 4, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $30.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| RA Capital Healthcare Fund LPCIK 0001315082 | Director |
| Ra Capital Management, L.P.CIK 0001346824 | Director |
| Kolchinsky PeterCIK 0001384859 | Director |
| Shah Rajeev M.CIK 0001619841 | Director |
| RA Capital Nexus Fund III, L.P.CIK 0001883840 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | Common Stock | PPurchaseAcquired | +1,176,470 | $25.50 | +$29,999,985 | 5,456,521 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.